These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21856700)

  • 1. Will recording of lung function fluctuation open the door to internet-guided treatment of asthma?
    Kupczyk M; Dahlén SE
    Thorax; 2011 Dec; 66(12):1019-20. PubMed ID: 21856700
    [No Abstract]   [Full Text] [Related]  

  • 2. What is "more effective asthma control"?
    O'Brien K; Bukstein D
    J Allergy Clin Immunol; 2001 Jun; 107(6):1107-9. PubMed ID: 11398094
    [No Abstract]   [Full Text] [Related]  

  • 3. Associations between fluctuations in lung function and asthma control in two populations with differing asthma severity.
    Thamrin C; Nydegger R; Stern G; Chanez P; Wenzel SE; Watt RA; FitzPatrick S; Taylor DR; Frey U
    Thorax; 2011 Dec; 66(12):1036-42. PubMed ID: 21602542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M
    Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilation subsensitivity to salbutamol after salmeterol.
    Ng HW
    Lancet; 1995 Oct; 346(8980):968; author reply 968-9. PubMed ID: 7564752
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of different long-term asthma treatments in subjects with mild-to-moderate asthma.
    Di Franco A; Giannini D; Bacci E; Dente FL; Vagaggini B; Paggiaro PL
    Monaldi Arch Chest Dis; 1999 Oct; 54(5):390-3. PubMed ID: 10741095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilation subsensitivity to salbutamol after salmeterol.
    Barnes N
    Lancet; 1995 Oct; 346(8980):968; author reply 968-9. PubMed ID: 7564751
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A; Jarvis B
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
    Chopra N; Williams M; Rimmer M; Kahl L; Jenkins M;
    Respir Med; 2005 Apr; 99 Suppl A():S1-S10. PubMed ID: 15777603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial.
    Turner MO; Johnston PR; Pizzichini E; Pizzichini MM; Hussack PA; Hargreave FE
    Can Respir J; 1998; 5(4):261-8. PubMed ID: 9753527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung blood flow must be considered when prescribing a long-acting β2-agonist/inhaled corticosteroid combination.
    Cazzola M; Matera MG
    Chest; 2012 May; 141(5):1134-1136. PubMed ID: 22553257
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
    Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA
    MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PP-ICONS--another tool to help interpret asthma utilization studies.
    Crownover BK
    J Manag Care Pharm; 2006 May; 12(4):341-2. PubMed ID: 16792440
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
    Sheth K; Borker R; Emmett A; Rickard K; Dorinsky P
    Pharmacoeconomics; 2002; 20(13):909-18. PubMed ID: 12381242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of salmeterol and fluticasone propionate alone and in combination on airway blood flow in patients with asthma.
    Mendes ES; Rebolledo P; Wanner A
    Chest; 2012 May; 141(5):1184-1189. PubMed ID: 21980058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmeterol compared with current therapies in chronic asthma.
    Adinoff AD; Schwartz HJ; Rickard KA; Yancey SW; Swearingen BE
    J Fam Pract; 1998 Oct; 47(4):278-84. PubMed ID: 9789513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.